Vertex Receives CHMP Positive Opinion For The First CRISPR/Cas9 Gene-Edited Therapy CASGEVY

Vertex Advances Inaxaplin Into Phase 2/3 Trial To Treat APOL1-Mediated Kidney Disease

Vertex Pharmaceuticals Inc. (VRTX) announced Monday that inaxaplin (VX-147) has advanced into the Phase 3 portion of the global Phase 2/3 pivotal clinical trial in APOL1-mediated kidney disease (AMKD), where a 45 mg once daily oral dose will be compared to placebo, on top of standard of care.

RTTNews | 499天前

Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology

Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).

RTTNews | 870天前

Vertex Pharma To Acquire ViaCyte For $320 Mln In Cash

Vertex Pharmaceuticals Inc. (VRTX) announced Monday that the company has entered into a definitive agreement under which Vertex will acquire privately-held biotechnology company ViaCyte for $320 million in cash.

RTTNews | 1129天前

Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes

Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes (T1D) with impaired hypoglycemic awareness and severe hypoglycemia.

RTTNews | 1135天前

Bay Street Likely To Open On Positive Note

Canadian stocks may open higher on Wednesday, amid continued optimism about Fed interest rate cut, and easing geopolitical tensions ahead of talks between U.S. President Donald Trump and Russian President Vladimir Putin that is scheduled to take place on Friday.

RTTNews | 2小時33分鐘前

U.S. Dollar Extends Fall Amid Fed Rate Cut Speculation

The U.S. dollar continued to trade lower against other major currencies in the European session on Wednesday, as the U.S. Consumer Price Index data from July has raised expectations that the Fed would lower interest rates in September.

RTTNews | 2小時58分鐘前

FTSE 100 Modestly Higher; Beazley Plunges Sharply

U.K. stocks are turning in a mixed performance on Wednesday with investors reacting to earnings, and awaiting fresh data and trade news for directional clues.

RTTNews | 3小時5分鐘前

CAC 40 Up Nearly 0.5%; Essilor Rises Sharply

French stocks are gaining some ground in positive territory on Wednesday, extending previous session's rise, amid continued optimism the Fed will reduce interest rate next month, and on slightly easing concerns about tariff after the U.S. decided to extend its pause on higher tariffs against China till November 10.

RTTNews | 4小時10分鐘前

EURUSD	1.17177	GBPUSD	1.35676	AUDUSD	0.65492
USDJPY	147.101	USDCAD	1.37658	USDCHF	0.80409